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Abstract 
Hydrogen sulfide (H2S) has dual actions in the human 
body as an internally produced signaling molecule and 
a toxin, with intoxication leading to short and long term 
adverse neurological symptoms. However, the 
underlying mechanisms are still unknown. Our 
hypothesis is that neuroinflammation, characterized by 
an inflammatory response from agitated support 
neurons, can cause cell death by invoking the 
production of many damaging chemicals, called 
cytokines. To test this hypothesis we used 
immunostaining techniques to visualize the affected 
tissue; then using cytokine assays, measured the 
chemicals of interest in the brain tissue and blood of 
mice exposed to H2S by inhalation. Results show 
increased reactivity of neurons, starting around day 3 
post exposure. Understanding the basic mechanisms 
underlying neuroinflammation contributes to our long 
term objective of discovering countermeasures against 
and treatment of H2S induced neurodegeneration.  
 
• H2S is colorless, with a characteristic rotten egg odor  
• An occupational hazard in several industries 
including intensive swine confinement operations, 
petroleum and oil production; natural sources include 
volcanic gas 
• At high concentration (1000-2000 ppm) death is 
instantaneous. 
• Acute exposure  short and long term neurological 
sequelae: impaired motor function, memory loss and 
cognition disorders, seizures, hearing impairment, etc. 
• H2S is a noncompetitive inhibitor of cytochrome c 
oxidase, an enzyme used in mitochondrial ATP 
generation 
• No field treatment available for use by first 
responders 
• Neuroinflammation is a mechanism of degeneration 
in related disorders such as Alzheimer’s and 
Parkinson’s diseases 
 Objective: 
To characterize inflammatory biomarkers of toxicity 
that can be targeted for treatment of H2S induced 
neurodegeneration 
• There is damage occurring in the brains of  H2S-
treated mice, with the most sensitive area being the 
inferior colliculus 
• Mice exposed to H2S show an increase in 
sensitivity to the gas suggesting cumulative effects 
• This damage in mice leads to adverse effects  
similar to those seen in humans exposed to the gas, 
such as neurodegeneration and motor impairment 
• Profiles of cytokine expression were not greatly 
altered in serum. 
• Exposure to H2S induces upregulation of IL-1β and 
TNF-α, biomarkers for neuroinflammation, while 
downregulating VEGF, which is important for its 
protective role against stress in the brain 
• Future directions include investigating activation 
of the inflammasome and neuroprotective effects 
of therapies 
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Fig. 4. Behavior changes in control mice vs. H2S-treated mice. H2S treated mice 
show a significant reduction in weight over the course of 7 days, impaired 
motor activity, and increasing sensitivity to H2S exposure with subsequent 
treatments. 
Mitochondrion 
ATP 
ROS 
Astrocyte 
Microglia 
Cytokines:  
IL-6, TNF-α, 
IL-17, IL-1 
  
Neuron 
Death 
IL-4, TNF-α, 
IL-6, IL-1β 
  
Day                      1            2           3            4           5            6            7 
Duration         40min    15min               
Group                 B                          C                                                   A&D               
Fig. 1. Diagram of exposure day, duration of exposure, euthanization days (red x) 
and animal behavior days (mouse). Group A: Control (Breathing air), Groups B – 
D (H2S) . 
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Introduction Fig. 2. Hypothetical neuroinflammatory scheme showing signaling cascade after 
mitochondrial injury caused by H2S toxicity. Reactive astrocytes release 
cytokines, propagating an intense inflammatory response 
 
 
 
 
 
 
 
• For Brain: Tissue samples homogenized, lysates 
analyzed 
• For Serum: Samples added  
 to a multiplex assay plate  
 containing beads  
 conjugated with  capture  
 antibody  quantify  
 analyte concentration by light emission 
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Fig. 3. Bead conjugated 
with antibody 
Fig. 5. H&E staining of the inferior colliculus in the mouse brainstem. 
Gross lesions observable by day 7.  
Cytokine Expression Quantified using Luminex  
 
Fig. 6. Cytokines expressed in serum of mice samples. Purple 
graphs indicate an n > 3. Red graphs indicate an < 3 values used in 
calculation. * indicates p<.05. 
Fig. 7. Cytokines expressed in brain tissue homogenate of mice samples 
from central inferior colliculus.  
 
Histopathology 
 
Luminex 
Meso Scale Discovery (MSD) 
• For Brain and Serum: Samples added to a 
multiplex high binding carbon assay plate  
electrical stimulation cause light emission from 
electrochemiluminescent tag  quantify analyte 
concentration by light intensity 
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Fig. 9. Cytokine expression in the serum of mice samples. 
Fig. 8. Cytokine expression in the central inferior colliculus of mice 
samples. * indicates p < 0.05  *** indicates p < 0.0005 
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Slope of treatment mice 
weights are 
significantly less than 
control mice. P <  0.005 
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Treatment Paradigm 
Proposed Schematic 
Cytokine Quantification 
• 5 mice/group (4 groups total) exposed to H2S + 
breathing air via inhalation; euthanization 2 hours 
post exposure on last day of treatment 
• Upon euthanization, brain tissue collected via 
decapitation and blood collected for serum 
